| 000 | 01460 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517210723.0 | ||
| 264 | 0 | _c20190927 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1542-6270 | ||
| 024 | 7 |
_a10.1177/1060028018768808 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorizio, Paige | |
| 245 | 0 | 0 |
_aDenosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _c10 2018 |
||
| 300 |
_a1031-1041 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDenosumab _xeconomics |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 |
_aFractures, Bone _xepidemiology |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 |
_aPatient Preference _xstatistics & numerical data |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aBurkhart, Jena I | |
| 700 | 1 | _aOzawa, Sachiko | |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 52 _gno. 10 _gp. 1031-1041 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1060028018768808 _zAvailable from publisher's website |
| 999 |
_c28249438 _d28249438 |
||